Aspirin Responsiveness in a Cohort of Pediatric Patients with Right Ventricle to Pulmonary Artery Conduits and Transcatheter Valve Replacement Systems
Pediatric Cardiology · 2025
DOI: 10.1007/s00246-024-03449-1 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pediatric Cardiology, 2025. Verfasst von Sean T Kelleher und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Cardiology, Children's Health Ireland at Crumlin, Dublin, Ireland. Hauptthemen laut MEDLINE: Aspirin, Platelet Aggregation Inhibitors, Pulmonary Artery, Heart Ventricles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Children's Research Centre, University College Dublin.
Abstract (Originalsprache)
The aim of this study was to determine the rate of aspirin responsiveness in a cohort of pediatric patients with in situ xenograft valved right ventricle to pulmonary artery (RV-PA) conduits and/or transcatheter valve replacements (TVR). Aspirin is routinely prescribed to these patients. Optimizing anti-platelet therapy could promote valve longevity and reduce the risk of infective endocarditis in this at-risk group. This was a prospective, observational study. Patients were recruited from both ward and outpatient settings. Patients were eligible if under 18 years and taking aspirin. Non-response to aspirin was defined as > 20% platelet aggregation using light transmission platelet aggregometry (LTA) and < 50% platelet inhibition by thromboelastography with platelet mapping (TEGPM). Participants were invited to provide a confirmatory sample in cases of aspirin resistance and dose adjustments were made. Thirty patients participated. Median age was 9 years (2 months to 18 years). The majority (93%) had complex right ventricular outflow tract pathology. 13 (43%) had an RV-PA conduit and 24 (80%) had a TVR, with valve situated in conduit in 7 (23%) cases. Rate of aspirin non-response on initial testing was 23% ( n = 7/30) with median LTA 74.55% (60–76%) and TEG 13.25% (0–44%) in non-responders. Non-responders were more likely to be under 1 year. Two patients required dose increases and one patient non-adherence to dose was identified. Four patients on repeat testing were responsive to aspirin by laboratory tests. The rate of aspirin non-response on laboratory testing in this cohort of patients was 23% and resulted in therapeutic intervention in 10%.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatric Cardiology, Children's Health Ireland at Crumlin, Dublin, Ireland.
- Department of Coagulation/Haematology, Children's Health Ireland at Crumlin, Dublin, Ireland.
- School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland.
- National Children's Research Centre, Children's Health Ireland, Dublin, Ireland.
- School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons Ireland, Dublin, Ireland.
- Department of Paediatric Pharmacy, Children's Health Ireland at Crumlin, Dublin, Ireland.
Förderung
- National Children's Research Centre
- University College Dublin
Zitieren
APA
Kelleher, S. T., Regan, I. E., Cox, D., Shaw, K., Franklin, O., Kenny, D. P., Walsh, K. P., & McMahon, C. J. (2025). Aspirin Responsiveness in a Cohort of Pediatric Patients with Right Ventricle to Pulmonary Artery Conduits and Transcatheter Valve Replacement Systems. Pediatric Cardiology. https://doi.org/10.1007/s00246-024-03449-1
Vancouver
Kelleher ST, Regan IE, Cox D, Shaw K, Franklin O, Kenny DP, et al. Aspirin Responsiveness in a Cohort of Pediatric Patients with Right Ventricle to Pulmonary Artery Conduits and Transcatheter Valve Replacement Systems. Pediatric Cardiology. 2025. doi:10.1007/s00246-024-03449-1
BibTeX
@article{Kelleher2025,
author = {Kelleher, Sean T and Regan, Irene E and Cox, Dermot and Shaw, Kathryn and Franklin, Orla and Kenny, Damien P and Walsh, Kevin P and McMahon, Colin J},
title = {Aspirin Responsiveness in a Cohort of Pediatric Patients with Right Ventricle to Pulmonary Artery Conduits and Transcatheter Valve Replacement Systems},
journal = {Pediatric Cardiology},
year = {2025},
doi = {10.1007/s00246-024-03449-1}
}
EUVIMED